Markets
Stocks
Funds
Sectors
Tools
Treasury & Bonds
Overview
Market News
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
My Portfolio
Pieris Pharma (NQ: PIRS)
3.070 USD  +0.080 (+2.68%)
Official Closing Price  /  Updated: 4:42 PM EST, Feb 15, 2019  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 369,200
Open 3.010
Bid (Size) 3.010 (1)
Ask (Size) 5.400 (5)
Prev. Close 2.990
Today's Range 2.910 - 3.150
52wk Range 2.390 - 9.312
Shares Outstanding 53,980,359
Dividend Yield N/A
Performance
YTD
+5.14%
+5.14%
1 Month
+8.87%
+8.87%
3 Month
-11.78%
-11.78%
6 Month
-39.69%
-39.69%
1 Year
-65.39%
-65.39%
Top News
More News
New Research: Key Drivers of Growth for Martin Midstream Partners, Galectin Therapeutics, Mountain Province Diamonds, MINDBODY, Pareteum, and Pieris Pharmaceuticals — Factors of Influence, Major Initi
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Martin Midstream... Read More
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Present at Investor Conferences in November
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and... Read More
from GlobeNewswire News Releases
More News
Read More
Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
from GlobeNewswire News Releases
Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018
from GlobeNewswire News Releases
Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
from GlobeNewswire News Releases
First Week of September 20th Options Trading For Pieris Pharmaceuticals (PIRS)
category Stocks
from Market News Video
New Research Coverage Highlights Dorian LPG, Avadel Pharmaceuticals, Pieris Pharmaceuticals, Resolute Energy, American Public Education, and THL Credit — Consolidated Revenues, Company Growth, and Exp
from GlobeNewswire News Releases
IWO's Underlying Holdings Imply 27% Gain Potential
category ETFs
from ETF Channel
Analysts Anticipate 25% Gains Ahead For IEIH
category ETFs
from ETF Channel
We Did The Math IEIH Can Go To $32
category ETFs
from ETF Channel
48 Biggest Movers From Friday
category News , BLFS , IO , and 60 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.